Emerging pillar industry position of biomedicine strengthened, Hang Seng Biotechnology ETF Guotai (520930) surged over 3% during intraday trading

NightAirdropper · 2026-03-18T07:24:04+00:00

Biotech and pharmaceuticals have been designated as an emerging pillar industry, with Guotai Hang Seng Biotech ETF (520930) stock price rising over 3%. Xingye Securities points out that innovation and internationalization are the main development themes of the industry, and China's innovative drugs have competitive advantages. Investors can pay attention to the Guotai Hang Seng Biotech ETF to establish positions. Risk disclosures emphasize the analytical nature of individual stocks and remind investors to carefully select products.

NightAirdropper

2026-03-18 07:24:04

Abstract generation in progress

Biopharmaceuticals’ status as an emerging pillar industry is being elevated. On March 17, Hang Seng Biotech ETF Guotai (520930) surged over 3% intraday.

Industrial Securities pointed out that this year’s government work report proposed “implementing industrial innovation projects” and focused on developing biopharmaceuticals as an emerging pillar industry. This is the first time the biopharmaceutical industry has been given the strategic positioning of a “pillar industry” in top-level national planning. Regarding industry strategy, “innovation + internationalization” will remain the core theme. Chinese innovative drugs have advantages in high efficiency and low-cost development, with competitive edges in hot technology tracks like ADC and bispecific antibodies. The prosperity of the innovative drug industry chain continues to rise, and based on investment and financing data, orders, and performance, the current recovery trend is relatively certain.

The Hang Seng Biotech Index focuses on the “crown jewel” of innovative drugs, offering three major advantages: leading companies gathering, scarce futures liquidity, and high elasticity & high Sharpe ratio. Investors wishing to conveniently participate in core innovative drug leaders can focus on the Hang Seng Biotech ETF Guotai (520933) for one-click deployment.

Risk Reminder: Mentioning individual stocks is only for industry event analysis and does not constitute any stock recommendation or investment advice. Short-term index fluctuations are for reference only and do not predict future performance, nor do they constitute a promise or guarantee of fund performance. Opinions may change with market conditions and do not constitute investment advice or commitments. Different funds have different risk and return characteristics; investors are advised to carefully read the fund legal documents, fully understand product features, risk levels, and distribution principles, and choose products that match their risk tolerance. Invest cautiously.

Daily Economic News

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.